Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 24, 2026
Why Is Aehr Test Systems (AEHR) Stock Down -13.42% Today?

Why Is Aehr Test Systems (AEHR) Stock Down -13.42% Today?

Key Takeaways

  • Aehr Test Systems (AEHR) plunged approximately 13.42% in Friday's trading session, falling to $76.63 from a prior close of $88.51, as a broad semiconductor sell-off triggered heavy profit-taking in the high-beta stock.
  • The primary catalyst was a sector-wide rout in chip stocks, with the PHLX Semiconductor Index sliding over 2% and memory names like MU and SNDK down 6% to 10%, sparked by an overnight KOSPI sell-off in South Korea.
  • Secondary drivers included cooling enthusiasm for AI hardware valuations, geopolitical tensions in the Middle East, and rising Treasury yields pressuring growth stocks.
  • No company-specific negative news accompanied the decline; Aehr recently posted record quarterly bookings of $60.7 million and issued fiscal 2027 revenue guidance of $130 million to $150 million.
  • Traders are now watching whether the stock can stabilize above its 200-day moving average near $60 and whether the semiconductor sector sell-off extends into next week.

Opening Summary

Aehr Test Systems (AEHR), a Fremont, California-based designer and manufacturer of semiconductor test and burn-in equipment used for wafer-level reliability assessment and quality assurance, saw its shares tumble approximately 13.42% on Friday. The stock traded at $76.63 during the session, down sharply from the previous day's closing price of $88.51. The decline unfolded against the backdrop of a broad chip-sector sell-off that swept through global markets, with no company-specific negative developments to account for the severity of the move. Instead, the drop reflects aggressive profit-taking in one of the year's biggest AI-driven winners amid deteriorating risk appetite across the semiconductor complex.

Broad Semiconductor Rout Drives the Sell-Off

The dominant force behind Friday's decline in AEHR was a sector-wide exodus from semiconductor stocks. The sell-off originated overnight in South Korea, where the KOSPI index tumbled more than 6%, dragged lower by steep drops of over 7% in Samsung Electronics and SK Hynix. That weakness cascaded into U.S. trading, sending the PHLX Semiconductor Index down more than 2%. Memory-chip names bore the brunt of the selling, with MU falling as much as 7% and SNDK plunging nearly 10%. Even INTC, which reported second-quarter results that blew past Wall Street expectations with 25% revenue growth and earnings that doubled analyst estimates, slid more than 3% after an initial pre-market surge. The indiscriminate selling underscored a broader rotation out of AI-linked chip names that had powered markets higher for much of 2026.

Profit-Taking After a Parabolic Rally

Friday's decline also reflects a natural unwind of stretched positioning following an extraordinary run for AEHR. The stock has surged more than 300% year-to-date, propelled by its successful pivot from electric-vehicle silicon carbide testing toward the faster-growing market for AI processor burn-in and reliability screening. The rally accelerated sharply after the company's fiscal fourth-quarter 2026 earnings release on July 14, which revealed record quarterly bookings of $60.7 million, an effective backlog of $100.6 million, and fiscal 2027 revenue guidance of $130 million to $150 million — roughly triple fiscal 2026's $50 million. After such a powerful run, the stock became highly vulnerable to any shift in risk sentiment. With a beta near 3.2, AEHR amplifies market moves in both directions, making it a prime target for profit-taking once sector momentum turns.

Macro Headwinds Compound the Pressure

Broader macroeconomic factors added weight to the sell-off. Renewed geopolitical tensions in the Middle East stoked risk aversion across equity markets, while rising Treasury yields made high-growth, high-valuation names less attractive by raising the opportunity cost of holding risk assets. These conditions have fueled what some market strategists describe as a "reversion trade" — a rotation out of the year's biggest winners. The Nasdaq Composite, which had been on a three-day losing streak heading into Friday, remained under pressure, with the index heading for a weekly loss. The combination of sector rotation, macro uncertainty, and elevated valuations created a perfect storm for volatile small- and mid-cap names like AEHR.

Market Context and Trading Activity

Trading volume in AEHR was elevated relative to recent sessions, consistent with a high-conviction distribution event. The stock sliced below its 50-day simple moving average, which had been hovering near the $94 level, though it remains comfortably above its 200-day moving average near $60. The price action represented a continuation of the pullback that began after the stock hit an intraday high above $110 on July 15, the day after earnings. Including Friday's decline, the shares have now given back roughly 30% from that peak. The move also aligned with weakness across the broader semiconductor equipment peer group, with names like TER and CRDO also posting notable losses.

What Comes Next for AEHR

Looking ahead, AEHR faces a critical test of whether its fundamental story can reassert itself once the current wave of sector-wide selling subsides. The company's record backlog, multiple production wins in AI processors and silicon photonics, and ambitious fiscal 2027 growth targets provide a robust fundamental underpinning. Management has emphasized that demand from AI-related applications continues to accelerate, with the silicon carbide market also showing early signs of stabilization. However, ongoing GAAP losses and cash burn remain points of vulnerability, and the stock's extreme volatility means that sentiment can shift rapidly in either direction. Investors will be closely monitoring stabilization in the PHLX Semiconductor Index, any further customer announcements from key hyperscaler and foundry partners, and the trajectory of AI capital spending into the second half of 2026. The company's next quarterly report is not due for several months, leaving the stock largely at the mercy of sector-level dynamics in the near term.

Trending AI Robots

In volatile market environments like today's semiconductor sell-off, automated trading strategies can help investors navigate sharp swings with discipline and speed. Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, each calibrated to distinct strategies, timeframes, and performance metrics. Only the strongest performers under current market conditions are featured in the curated Trending AI Robots section, providing traders with a streamlined view of the algorithms best adapted to prevailing conditions. Explore the page to see which bots are currently leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AEHR

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


AEHR in +21.68% Uptrend, advancing for three consecutive days on August 12, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on AEHR as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on August 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

AEHR moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AEHR crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 258 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AEHR broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AEHR's P/B Ratio (19.194) is slightly higher than the industry average of (9.013). P/E Ratio (19.449) is within average values for comparable stocks, (176.968). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.654). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (79.365) is also within normal values, averaging (38.579).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 67.85B. The market cap for tickers in the group ranges from 555.66K to 689.17B. ASML holds the highest valuation in this group at 689.17B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 7%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 46%. AEHR experienced the highest price growth at 31%, while SMTK experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 1%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 32
Price Growth Rating: 44
SMR Rating: 74
Profit Risk Rating: 60
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
AEHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of burn-in and test equipment for semiconductor manufacturing

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
400 Kato Terrace
Phone
+1 510 623-9400
Employees
136
Web
https://www.aehr.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.